Practice Guideline
. 2020 Apr;18(4):380-391. doi: 10.6004/jnccn.2020.0017. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020 Robert Pilarski 2 , Matthew B Yurgelun 3 , Michael P Berry 4 , Saundra S Buys 5 , Patricia Dickson 6 , Susan M Domchek 7 , Ahmed Elkhanany 8 , Susan Friedman 9 , Judy E Garber 3 , Michael Goggins 10 , Mollie L Hutton 11 , Seema Khan 12 , Catherine Klein 13 , Wendy Kohlmann 5 , Allison W Kurian 14 , Christine Laronga 15 , Jennifer K Litton 16 , Julie S Mak 17 , Carolyn S Menendez 18 , Sofia D Merajver 19 , Barbara S Norquist 20 , Kenneth Offit 21 , Tuya Pal 22 , Holly J Pederson 23 , Gwen Reiser 24 , Kristen Mahoney Shannon 25 , Kala Visvanathan 10 , Jeffrey N Weitzel 26 , Myra J Wick 27 , Kari B Wisinski 28 , Mary A Dwyer 29 , Susan D Darlow 29Affiliations
AffiliationsItem in Clipboard
Practice Guideline
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020Mary B Daly et al. J Natl Compr Canc Netw. 2020 Apr.
. 2020 Apr;18(4):380-391. doi: 10.6004/jnccn.2020.0017. Authors Mary B Daly 1 , Robert Pilarski 2 , Matthew B Yurgelun 3 , Michael P Berry 4 , Saundra S Buys 5 , Patricia Dickson 6 , Susan M Domchek 7 , Ahmed Elkhanany 8 , Susan Friedman 9 , Judy E Garber 3 , Michael Goggins 10 , Mollie L Hutton 11 , Seema Khan 12 , Catherine Klein 13 , Wendy Kohlmann 5 , Allison W Kurian 14 , Christine Laronga 15 , Jennifer K Litton 16 , Julie S Mak 17 , Carolyn S Menendez 18 , Sofia D Merajver 19 , Barbara S Norquist 20 , Kenneth Offit 21 , Tuya Pal 22 , Holly J Pederson 23 , Gwen Reiser 24 , Kristen Mahoney Shannon 25 , Kala Visvanathan 10 , Jeffrey N Weitzel 26 , Myra J Wick 27 , Kari B Wisinski 28 , Mary A Dwyer 29 , Susan D Darlow 29 AffiliationsItem in Clipboard
AbstractThe NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic provide recommendations for genetic testing and counseling for hereditary cancer syndromes, and risk management recommendations for patients who are diagnosed with syndromes associated with an increased risk of these cancers. The NCCN panel meets at least annually to review comments, examine relevant new data, and reevaluate and update recommendations. These NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding criteria for high-penetrance genes associated with breast and ovarian cancer beyond BRCA1/2, pancreas screening and genes associated with pancreatic cancer, genetic testing for the purpose of systemic therapy decision-making, and testing for people with Ashkenazi Jewish ancestry.
Similar articlesDaly MB, Pilarski R, Axilbund JE, Berry M, Buys SS, Crawford B, Farmer M, Friedman S, Garber JE, Khan S, Klein C, Kohlmann W, Kurian A, Litton JK, Madlensky L, Marcom PK, Merajver SD, Offit K, Pal T, Rana H, Reiser G, Robson ME, Shannon KM, Swisher E, Voian NC, Weitzel JN, Whelan A, Wick MJ, Wiesner GL, Dwyer M, Kumar R, Darlow S. Daly MB, et al. J Natl Compr Canc Netw. 2016 Feb;14(2):153-62. doi: 10.6004/jnccn.2016.0018. J Natl Compr Canc Netw. 2016. PMID: 26850485
Daly MB, Pilarski R, Berry M, Buys SS, Farmer M, Friedman S, Garber JE, Kauff ND, Khan S, Klein C, Kohlmann W, Kurian A, Litton JK, Madlensky L, Merajver SD, Offit K, Pal T, Reiser G, Shannon KM, Swisher E, Vinayak S, Voian NC, Weitzel JN, Wick MJ, Wiesner GL, Dwyer M, Darlow S. Daly MB, et al. J Natl Compr Canc Netw. 2017 Jan;15(1):9-20. doi: 10.6004/jnccn.2017.0003. J Natl Compr Canc Netw. 2017. PMID: 28040716
Gupta S, Provenzale D, Llor X, Halverson AL, Grady W, Chung DC, Haraldsdottir S, Markowitz AJ, Slavin TP Jr, Hampel H; CGC; Ness RM, Weiss JM, Ahnen DJ, Chen LM, Cooper G, Early DS, Giardiello FM, Hall MJ, Hamilton SR, Kanth P, Klapman JB, Lazenby AJ, Lynch PM, Mayer RJ, Mikkelson J; CGC; Peter S, Regenbogen SE, Dwyer MA; CGC; Ogba N. Gupta S, et al. J Natl Compr Canc Netw. 2019 Sep 1;17(9):1032-1041. doi: 10.6004/jnccn.2019.0044. J Natl Compr Canc Netw. 2019. PMID: 31487681
Marshall M, Solomon S. Marshall M, et al. Plast Surg Nurs. 2007 Jul-Sep;27(3):124-7. doi: 10.1097/01.PSN.0000290280.48197.e7. Plast Surg Nurs. 2007. PMID: 17901820 Review.
Graffeo R, Livraghi L, Pagani O, Goldhirsch A, Partridge AH, Garber JE. Graffeo R, et al. Breast Cancer Res Treat. 2016 Dec;160(3):393-410. doi: 10.1007/s10549-016-4003-9. Epub 2016 Oct 12. Breast Cancer Res Treat. 2016. PMID: 27734215 Review.
Meiser B, Kaur R, Morrow A, Peate M, Wong WKT, McPike E, Cops E, Nichols C, Austin R, Fine M, Thrupp L, Ward R, Macrae F, Hiller JE, Trainer AH, Mitchell G; ICCon Audit Study Collaborative Group. Meiser B, et al. Hered Cancer Clin Pract. 2021 Apr 9;19(1):24. doi: 10.1186/s13053-021-00180-3. Hered Cancer Clin Pract. 2021. PMID: 33836815 Free PMC article.
Mighton C, Shickh S, Uleryk E, Pechlivanoglou P, Bombard Y. Mighton C, et al. Genet Med. 2021 Jan;23(1):22-33. doi: 10.1038/s41436-020-00957-2. Epub 2020 Sep 14. Genet Med. 2021. PMID: 32921787
Chiang YC, Lin PH, Cheng WF. Chiang YC, et al. Front Oncol. 2021 Oct 14;11:675972. doi: 10.3389/fonc.2021.675972. eCollection 2021. Front Oncol. 2021. PMID: 34722237 Free PMC article. Review.
Ku GY, Kemel Y, Maron SB, Chou JF, Ravichandran V, Shameer Z, Maio A, Won ES, Kelsen DP, Ilson DH, Capanu M, Strong VE, Molena D, Sihag S, Jones DR, Coit DG, Tuvy Y, Cowie K, Solit DB, Schultz N, Hechtman JF, Offit K, Joseph V, Mandelker D, Janjigian YY, Stadler ZK. Ku GY, et al. JAMA Netw Open. 2021 Jul 1;4(7):e2114753. doi: 10.1001/jamanetworkopen.2021.14753. JAMA Netw Open. 2021. PMID: 34251444 Free PMC article.
Lang GT, Shi JX, Huang L, Cao AY, Zhang CH, Song CG, Zhuang ZG, Hu X, Huang W, Shao ZM. Lang GT, et al. Ann Transl Med. 2020 Nov;8(21):1417. doi: 10.21037/atm-20-2999. Ann Transl Med. 2020. PMID: 33313162 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3